Business Standard

Sunset for public sector drug makers

Of the five units it owns, New Delhi wants to close two and sell another two

Pharmaceuticals, drugs, Indian Drugs & Pharmaceuticals, pharma industry, India
Premium

Indian Drugs and Pharmaceuticals’ declared mandate was not to make a profit but to supply affordable life-saving drugs.

Subir Roy Kolkata
Public sector pharmaceutical companies, which had long dropped out of the media’s sight, were recently briefly back among the headlines. The central government effectively decided to close four of the five which come under it and are loss-making. (Only Karnataka Antibiotics & Pharmaceuticals makes a profit.) While two will be closed straightaway, an attempt at strategic sale will be made for the other two. But the way the news reports were worded, all four seem eventually headed for the chopping block.

The two that are clearly headed for closure are Indian Drugs & Pharmaceuticals and Rajasthan Drugs & Pharmaceuticals. The

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in